In the BioHarmony Drug Report Database

"Preview" Icon

Tranylcypromine

Parnate (tranylcypromine) is a small molecule pharmaceutical. Tranylcypromine was first approved as Parnate on 1985-08-16. It is used to treat depressive disorder and post-traumatic stress disorders in the USA. The pharmaceutical is active against amine oxidase [flavin-containing] B and amine oxidase [flavin-containing] A. In addition, it is known to target lysine-specific histone demethylase 1A and prostacyclin synthase.

 

Trade Name

 

Parnate
 

Common Name

 

tranylcypromine
 

ChEMBL ID

 

CHEMBL3989843
 

Indication

 

depressive disorder, post-traumatic stress disorders
 

Drug Class

 

Image (chem structure or protein)

Tranylcypromine structure rendering